ROSEN, National Trial Lawyers, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLNNewsfile Corp • 07/23/22
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLNPRNewsWire • 07/23/22
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Molecular Partners AG of Class Action Lawsuit and Upcoming Deadline and Directors - MOLNPRNewsWire • 07/21/22
ROSEN, A Leading Law Firm, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLNNewsfile Corp • 07/21/22
Molecular Partners Announces Publication in Nature Biotechnology Detailing Design and Mechanism of Ensovibep DARPin Antiviral for SARS-CoV-2GlobeNewsWire • 07/21/22
MOLECULAR PARTNERS AG (MOLN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Molecular Partners AG (MOLN)Newsfile Corp • 07/20/22
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Molecular Partners AG of Class Action Lawsuit and Upcoming Deadline and Directors - MOLNNewsfile Corp • 07/19/22
Bronstein, Gewirtz & Grossman, LLC Notifies Molecular Partners AG (MOLN) Investors of Class Action and Encourages Investors to Contact the FirmBusiness Wire • 07/19/22
INVESTOR NOTICE: Molecular Partners AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MOLNBusiness Wire • 07/18/22
MOLN INVESTOR NOTICE: ROSEN, Top Ranked Investor Counsel, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLNNewsfile Corp • 07/17/22
INVESTOR DEADLINE: Molecular Partners AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MOLNPRNewsWire • 07/16/22
Shareholder Update: Robbins LLP Reminds Investors of Class Action Against Molecular Partners AG (MOLN)Business Wire • 07/15/22
Bronstein, Gewirtz & Grossman, LLC Notifies Molecular Partners AG (MOLN) Investors of Class Action and Encourages Investors to Contact the FirmPRNewsWire • 07/15/22
MOLN INVESTOR ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLNPRNewsWire • 07/15/22
MOLECULAR PARTNERS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Molecular Partners AG and Encourages Investors to Contact the FirmBusiness Wire • 07/15/22
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Molecular Partners AG (MOLN)Business Wire • 07/14/22
INVESTOR ALERT: Molecular Partners AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MOLNBusiness Wire • 07/14/22
EQUITY ALERT: Rosen Law Firm Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action – MOLNBusiness Wire • 07/13/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Partners AG - MOLNPRNewsWire • 05/11/22
Molecular Partners to Participate in Upcoming Healthcare Investor ConferencesGlobeNewsWire • 05/11/22
Molecular Partners CEO, Patrick Amstutz, Elected President of the Swiss Biotech AssociationGlobeNewsWire • 05/03/22
Molecular Partners shares tumble 37% after Amgen returns rights to tumor treatment candidateMarket Watch • 04/27/22
